DewDiligence
3 years ago
MYOV bags European partner for Orgovyx:
https://www.globenewswire.com/news-release/2022/05/09/2438369/0/en/Myovant-Sciences-and-Accord-Healthcare-Ltd-Enter-into-Exclusive-License-Agreement-to-Commercialize-ORGOVYX-for-Advanced-Hormone-Sensitive-Prostate-Cancer-in-Europe.html Myovant Sciences and Accord Healthcare, Ltd. (Accord) today announced that they have entered into an exclusive license agreement for Accord to commercialize relugolix for the treatment of advanced hormone-sensitive prostate cancer under the trade name ORGOVYX (relugolix, 120 mg) in the European Economic Area, United Kingdom, Switzerland and Turkeyโฆ
โฆUnder the terms of the agreement, Myovant will receive an upfront payment of $50 million and is eligible to receive commercial launch, sales-based and other milestones totaling up to $90.5 million. In addition, Myovant is eligible to receive tiered royalties from the high-teens to mid-twenties on net sales.
winepro1
3 years ago
Cosa,
I see you are also into MYOV. I no longer post on AUPH as I am tired of BR, Cervelo, Whalatane, and Rosemount bomber, who I suspect are all questionable posters and now dominate a once good site. I was there due to Vidpok. You, zzaatt, and moosedogger would probably appreciate stocktwits AUPH much more. There is a good amount of fud posters but also some serious posters also that dig up much more good info. Just wanted to let you know.
Winepro1, ( aka HarryCrumb).